Growth Metrics

Organon (OGN) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to -$115.0 million.

  • Organon's Cash from Investing Activities fell 5333.33% to -$115.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$621.0 million, marking a year-over-year decrease of 10838.93%. This contributed to the annual value of -$513.0 million for FY2024, which is 9730.77% down from last year.
  • Latest data reveals that Organon reported Cash from Investing Activities of -$115.0 million as of Q3 2025, which was down 5333.33% from -$38.0 million recorded in Q2 2025.
  • In the past 5 years, Organon's Cash from Investing Activities ranged from a high of -$38.0 million in Q1 2021 and a low of -$296.0 million during Q4 2024
  • Moreover, its 5-year median value for Cash from Investing Activities was -$75.0 million (2024), whereas its average is -$105.2 million.
  • In the last 5 years, Organon's Cash from Investing Activities tumbled by 42978.72% in 2021 and then soared by 7417.84% in 2023.
  • Over the past 5 years, Organon's Cash from Investing Activities (Quarter) stood at -$133.0 million in 2021, then surged by 54.14% to -$61.0 million in 2022, then crashed by 32.79% to -$81.0 million in 2023, then crashed by 265.43% to -$296.0 million in 2024, then soared by 61.15% to -$115.0 million in 2025.
  • Its Cash from Investing Activities stands at -$115.0 million for Q3 2025, versus -$38.0 million for Q2 2025 and -$172.0 million for Q1 2025.